Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): a state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): a state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

The guidelines for classification, prognostication, and response assessment of myelodysplastic syndromes/neoplasms (MDS) have all recently been updated. In this report on behalf of the International Consortium for MDS (icMDS) we summarize these developments. We first critically examine the updated W...

書目詳細資料
Main Authors:	Stahl, M, Bewersdorf, JP, Xie, Z, Porta, MGD, Komrokji, R, Xu, ML, Abdel-Wahab, O, Taylor, J, Steensma, DP, Starczynowski, DT, Sekeres, MA, Sanz, G, Sallman, DA, Roboz, GJ, Platzbecker, U, Patnaik, MM, Padron, E, Odenike, O, Nimer, SD, Nazha, A, Majeti, R, Loghavi, S, Little, RF, List, AF, Kim, TK, Hourigan, CS, Hasserjian, RP, Halene, S, Griffiths, EA, Gore, SD, Greenberg, P, Figueroa, ME, Fenaux, P, Efficace, F, DeZern, AE, Daver, NG, Churpek, JE, Carraway, HE, Buckstein, R, Brunner, AM, Boultwood, J, Borate, U, Bejar, R, Bennett, JM, Wei, AH, Santini, V, Savona, MR, Zeidan, AM
格式:	Journal article
語言:	English
出版:	Elsevier 2023

相似書籍

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
由: Efficace, F, et al.
出版: (2024)

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
由: Fabio Efficace, et al.
出版: (2024-05-01)

S170: MYELODYSPLASTIC NEOPLASMS (MDS) CLASSIFICATION FROM WHO 2017 TO WHO 2022 AND ICC 2022): AN EXPANDED ANALYSIS OF 7017 PATIENTS ON BEHALF OF THE INTERNATIONAL CONSORTIUM FOR MDS (ICMDS)
由: Rami S. Komrokji, et al.
出版: (2023-08-01)

Generalized GM-MDS: Polynomial Codes Are Higher Order MDS
由: Brakensiek, Joshua, et al.
出版: (2024)

The weights in MDS codes
由: Ezerman, Martianus Frederic, et al.
出版: (2019)

Construction of MDS matrices
由: Peng-fei LI, et al.
出版: (2016-06-01)

Application of classical Hermitian self-orthogonal MDS codes to quantum MDS codes
由: Jin, Lingfei, et al.
出版: (2012)

PB1999: TOBACCO SMOKING IN MDS PATIENTS – ANALYSIS FROM THE MDS PALG REGISTRY
由: Rafal Machowicz, et al.
出版: (2023-08-01)

THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (t-MDS) IN CHILDHOOD: THE EXPERIENCE OF THE HELLENIC STUDY GROUP FOR MDS/JMML/SAA, MEMBER OF THE EWOG-MDS/SAA WORKING GROUP
由: Loizos Petrikkos, et al.
出版: (2023-12-01)

New quantum MDS codes
由: Zhang, Guanghui, et al.
出版: (2015)

Inherited predisposition to MDS/AML
由: Ana Rio Machin, et al.
出版: (2018-06-01)

The impact of spliceosome mutations in MDS
由: Jacqueline Boultwood, et al.
出版: (2019-06-01)

MDS-482 Impact of magrolimab in combination with azacitidine on red blood cells (RBCs) in patients with higher-risk myelodysplastic syndromes (HR MDS)
由: Chen, J, et al.
出版: (2022)

P771: PROGNOSTIC CHARACTERISTICS OF PATIENTS WITH MDS WITH ABERRATIONS OF CHROMOSOME 5. DATA FROM THE DÜSSELDORF MDS REGISTRY
由: F. Schulz, et al.
出版: (2022-06-01)

MDS plus data acquisition system
由: Stillerman, J.A., et al.
出版: (2015)

Diffusion analysis of EFN-MDS structure
由: Ibrahim, Subariah
出版: (2006)

Diffusion analysis of EFN-MDS structure
由: Ibrahim, Subariah, et al.
出版: (2006)

The role of innate immunity in MDS pathogenesis
由: David A. Sallman, et al.
出版: (2019-06-01)

High-risk MDS after HMAs
由: Lionel Adès
出版: (2019-06-01)

P743: THE PIVOTAL ROLE OF GLUTAMINOLYSIS IN MYELODYSPLASTIC SYNDROME (MDS): A NOVEL STRATEGY FOR THE TARGETED THERAPY OF MDS
由: S. Okabe, et al.
出版: (2022-06-01)

IMPLICATIONS OF NOVEL CLASSIFICATIONS OF MYELOID NEOPLASMS FOR CHILDHOOD MDS
由: Katherine R. Calvo
出版: (2023-12-01)

DHPLC analysis of the ATRX gene in myelodysplastic syndrome (MDS) associated with acquired alpha thalassemia (AT-MDS): Novel mutation detection despite somatic mosaicism.
由: Steensma, D, et al.
出版: (2003)

Integrated genetic, epigenetic, and immune landscape of mutant AML and higher risk MDS treated with azacitidine
由: Amer M. Zeidan, et al.
出版: (2024-06-01)

Application of constacyclic codes to quantum MDS codes
由: Chen, Bocong, et al.
出版: (2015)

A construction of MDS quantum convolutional codes
由: Zhang, Guanghui, et al.
出版: (2015)

Trisomy X and myelodysplastic syndrome (MDS) with eosinophilia
由: Mohd Tohit, Eusni Rahayu, et al.
出版: (2012)

On linear codes whose hermitian hulls are MDS
由: Luo, Gaojun, et al.
出版: (2024)

HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
由: Mazyar Shadman, et al.
出版: (2014-09-01)

Value-based adoption of MDS:an empirical investigation
由: ZHOU Yi1, et al.
出版: (2008-01-01)

Editorial: MDS: new scientific and clinical developments
由: Sabine Blum, et al.
出版: (2025-02-01)

Value-based adoption of MDS:an empirical investigation
由: ZHOU Yi1, et al.
出版: (2008-01-01)

Understanding iron homeostasis in MDS: the role of erythroferrone
由: Mohammed L. Abba, et al.
出版: (2024-05-01)

Controversies on the Consequences of Iron Overload and Chelation in MDS
由: Francesca Vinchi, et al.
出版: (2020-06-01)

Recent advances in MDS mutation landscape: splicing and signalling
由: Follo, MY, et al.
出版: (2019)

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective
由: Theo de Witte, et al.
出版: (2020-09-01)

P703: THE AIPSS-MDS MACHINE LEARNING MODEL PREDICTS OVERALL SURVIVAL AND LEUKEMIC TRANSFORMATION IN CMML: AN ANALYSIS OF THE SPANISH REGISTRY OF MDS
由: Adrian Mosquera-Orgueira, et al.
出版: (2023-08-01)

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
由: Malcovati, L, et al.
出版: (2020)

PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT-MDS-1)
由: A. DeZern, et al.
出版: (2022-06-01)

New Systematic MDS Array Codes With Two Parities
由: Lan Ma, et al.
出版: (2024-01-01)

MDS CODEC EVALUATION BASED ON PERCEPTUAL SOUND ATTRIBUTES
由: Marcelo Herrera Martínez, et al.
出版: (2014-12-01)